|Bid||12.50 x 800|
|Ask||0.00 x 800|
|Day's Range||13.84 - 14.61|
|52 Week Range||13.12 - 27.15|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Shares of biotech company Gossamer Bio tumbled in high volume Monday after rival pharmaceutical company Novartis scrapped an asthma treatment that failed to meet its goal in a Phase 3 study.
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
On a per-share basis, the San Diego-based company said it had a loss of 90 cents. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment ...